Metabolic dysfunction-associated fatty liver disease: from basic research to clinical application

被引：3
|
作者：
Yang, Ruixu [1 ]
Jin, Qian [1 ]
Fan, Jiangao [1 ,2 ]
机构：
[1] Shanghai Jiao Tong Univ, Dept Gastroenterol, Sch Med, Xinhua Hosp, Shanghai 200092, Peoples R China
[2] Shanghai Key Lab Pediat Gastroenterol & Nutr, Shanghai 200092, Peoples R China
来源：
CHINESE MEDICAL JOURNAL | 2022年 / 135卷 / 10期
基金：
中国国家自然科学基金;
关键词：
NONINVASIVE TESTS; STEATOHEPATITIS; MAFLD;
D O I：
10.1097/CM9.0000000000002136
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：1138 / 1140
页数：3
相关论文
共 50 条
  • [41] From Nonalcoholic Fatty Liver Disease to Metabolic Dysfunction-Associated Steatotic Liver Disease: Out with the Old, in with the New
    Razzak, Iyiad Alabdul
    Noureddin, Mazen
    Trivedi, Hirsh D.
    JOURNAL OF CLINICAL MEDICINE, 2024, 13 (03)
  • [42] Concordance between metabolic dysfunction-associated steatotic liver disease and nonalcoholic fatty liver disease
    Suzuki, Keito
    Tamaki, Nobuharu
    Kurosaki, Masayuki
    Takahashi, Yuka
    Yamazaki, Yudai
    Uchihara, Naoki
    Tanaka, Yuki
    Miyamoto, Haruka
    Yamada, Michiko
    Keitoku, Taisei
    Okada, Risa
    Higuchi, Mayu
    Takaura, Kenta
    Tanaka, Shohei
    Maeyashiki, Chiaki
    Yasui, Yutaka
    Tsuchiya, Kaoru
    Nakanishi, Hiroyuki
    Izumi, Namiki
    HEPATOLOGY RESEARCH, 2024, 54 (06) : 600 - 605
  • [43] Mediterranean diet affects the metabolic outcome of metabolic dysfunction-associated fatty liver disease
    Xiao, Yuji
    Zhang, Xue
    Yi, Dongxin
    Qiu, Fangyi
    Wu, Lei
    Tang, Yiyong
    Wang, Ningning
    FRONTIERS IN NUTRITION, 2023, 10
  • [44] Evaluation of the Impact of Metabolic Syndrome on Fibrosis in Metabolic Dysfunction-Associated Fatty Liver Disease
    Kani, Haluk Tarik
    Demirtas, Coskun Ozer
    Keklikkiran, Caglayan
    Ergenc, Ilkay
    Mehdiyev, Shahin
    Akdeniz, Esra
    Yilmaz, Yusuf
    TURKISH JOURNAL OF GASTROENTEROLOGY, 2021, 32 (08): : 661 - 666
  • [45] Metabolic dysfunction-associated fatty liver disease and atherosclerotic cardiovascular disease risk: Dual aetiology or metabolic dysfunction?
    Ma, Tianyi
    Yuan, Huawei
    Guo, Zhanfang
    LIVER INTERNATIONAL, 2024, 44 (11) : 3103 - 3104
  • [46] Associations of depression score with metabolic dysfunction-associated fatty liver disease and liver fibrosis
    Cai, Hongwei
    Zhang, Rui
    Zhao, Chuanhao
    Wang, Yuzhuo
    Tu, Xiaoming
    Duan, Weiwei
    JOURNAL OF AFFECTIVE DISORDERS, 2023, 334 : 332 - 336
  • [47] Impact of hypertension on liver fibrosis in patients with metabolic dysfunction-associated fatty liver disease
    Gao, Zhifeng
    Deng, Huan
    Qin, Bowen
    Bai, Liang
    Li, Jiangwei
    Zhang, Jian
    FRONTIERS IN MEDICINE, 2025, 12
  • [48] The Role of the Gut-Liver Axis in Metabolic Dysfunction-Associated Fatty Liver Disease
    Martin-Mateos, Rosa
    Albillos, Agustin
    FRONTIERS IN IMMUNOLOGY, 2021, 12
  • [49] Role of liver sinusoidal endothelial cell in metabolic dysfunction-associated fatty liver disease
    He, Qiongyao
    He, Wu
    Dong, Hui
    Guo, Yujin
    Yuan, Gang
    Shi, Xiaoli
    Wang, Dingkun
    Lu, Fuer
    CELL COMMUNICATION AND SIGNALING, 2024, 22 (01)
  • [50] Genetic variants associated with metabolic dysfunction-associated fatty liver disease in western China
    Liao, Shenling
    An, Kang
    Liu, Zhi
    He, He
    An, Zhenmei
    Su, Qiaoli
    Li, Shuangqing
    JOURNAL OF CLINICAL LABORATORY ANALYSIS, 2022, 36 (09)
12345